200 related articles for article (PubMed ID: 9205075)
61. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
Walsh MJ; Shue G; Spidoni K; Kapoor A
J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
[TBL] [Abstract][Full Text] [Related]
62. Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.
Goukassian D; Sanz-González SM; Pérez-Roger I; Font de Mora J; Ureña J; Andrés V
Br J Pharmacol; 2001 Apr; 132(7):1597-605. PubMed ID: 11264255
[TBL] [Abstract][Full Text] [Related]
63. Regulation of BRCA1 expression by the Rb-E2F pathway.
Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
[TBL] [Abstract][Full Text] [Related]
64. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.
Krek W; Ewen ME; Shirodkar S; Arany Z; Kaelin WG; Livingston DM
Cell; 1994 Jul; 78(1):161-72. PubMed ID: 8033208
[TBL] [Abstract][Full Text] [Related]
65. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Jul; 30(7):2869-74. PubMed ID: 20683025
[TBL] [Abstract][Full Text] [Related]
66. RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F.
Denis GV; Vaziri C; Guo N; Faller DV
Cell Growth Differ; 2000 Aug; 11(8):417-24. PubMed ID: 10965846
[TBL] [Abstract][Full Text] [Related]
67. Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase.
Pusch O; Soucek T; Hengstschläger-Ottnad E; Bernaschek G; Hengstschläger M
DNA Cell Biol; 1997 Jun; 16(6):737-47. PubMed ID: 9212167
[TBL] [Abstract][Full Text] [Related]
68. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.
Lai R; Medeiros LJ; Wilson CS; Sun NC; Koo C; McCourty A; Brynes RK
Mod Pathol; 1998 Jul; 11(7):642-7. PubMed ID: 9688185
[TBL] [Abstract][Full Text] [Related]
69. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation.
Dilla T; Romero J; Sanstisteban P; Velasco JA
Oncogene; 2002 Apr; 21(15):2376-86. PubMed ID: 11948421
[TBL] [Abstract][Full Text] [Related]
70. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways.
Israel K; Sanders BG; Kline K
Nutr Cancer; 1995; 24(2):161-9. PubMed ID: 8584452
[TBL] [Abstract][Full Text] [Related]
71. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint.
Krek W; Xu G; Livingston DM
Cell; 1995 Dec; 83(7):1149-58. PubMed ID: 8548802
[TBL] [Abstract][Full Text] [Related]
72. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.
Lee RJ; Albanese C; Fu M; D'Amico M; Lin B; Watanabe G; Haines GK; Siegel PM; Hung MC; Yarden Y; Horowitz JM; Muller WJ; Pestell RG
Mol Cell Biol; 2000 Jan; 20(2):672-83. PubMed ID: 10611246
[TBL] [Abstract][Full Text] [Related]
73. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.
Mudryj M; Devoto SH; Hiebert SW; Hunter T; Pines J; Nevins JR
Cell; 1991 Jun; 65(7):1243-53. PubMed ID: 1829647
[TBL] [Abstract][Full Text] [Related]
74. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
[TBL] [Abstract][Full Text] [Related]
75. Interferons alpha, beta and gamma induce different patterns of gene expression in cultured human epidermal keratinocytes.
Arany I; Arany M; Brysk H; Tyring SK; Brysk MM
In Vivo; 1997; 11(2):157-61. PubMed ID: 9179609
[TBL] [Abstract][Full Text] [Related]
76. GCIP, a novel human grap2 and cyclin D interacting protein, regulates E2F-mediated transcriptional activity.
Xia C; Bao Z; Tabassam F; Ma W; Qiu M; Hua S; Liu M
J Biol Chem; 2000 Jul; 275(27):20942-8. PubMed ID: 10801854
[TBL] [Abstract][Full Text] [Related]
77. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.
Sylvester AM; Chen D; Krasinski K; Andrés V
J Clin Invest; 1998 Mar; 101(5):940-8. PubMed ID: 9486962
[TBL] [Abstract][Full Text] [Related]
78. Differential modulation of cyclin gene expression by MYC.
Jansen-Dürr P; Meichle A; Steiner P; Pagano M; Finke K; Botz J; Wessbecher J; Draetta G; Eilers M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3685-9. PubMed ID: 8386381
[TBL] [Abstract][Full Text] [Related]
79. Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth.
Said TK; Moraes RC; Sinha R; Medina D
Breast Cancer Res; 2001; 3(2):122-33. PubMed ID: 11250759
[TBL] [Abstract][Full Text] [Related]
80. Role of extracellular signal-regulated kinase pathway in RRR-alpha-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells.
You H; Yu W; Munoz-Medellin D; Brown PH; Sanders BG; Kline K
Mol Carcinog; 2002 Apr; 33(4):228-36. PubMed ID: 11933076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
